Cardiovascular Toxicities of BTK Inhibitors in Chronic Lymphocytic LeukemiaCooper Quartermaine, Daniel Addison, John C. Byrd et al.|JACC CardioOncology|2023Cited by 107
Clinical activity of axicabtagene ciloleucel in adult patients with Richter syndromeAdam S. Kittai, Samantha Jaglowski, David A. Bond et al.|Blood Advances|2020Cited by 70
Ventricular arrhythmias and sudden death events following acalabrutinib initiationSeema A. Bhat, Daniel Addison, John Alan Gambril et al.|Blood|2022Cited by 68
The impact of increasing karyotypic complexity and evolution on survival in patients with CLL treated with ibrutinibAdam S. Kittai, Jennifer A. Woyach, Cecelia Miller et al.|Blood|2021Cited by 61
Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy for Richter Transformation: An International, Multicenter, Retrospective StudyAdam S. Kittai, Philip A. Thompson, David A. Bond et al.|Journal of Clinical Oncology|2024Cited by 43